Emdeon Inc. (NYSE: EM), a leading provider of healthcare revenue and payment cycle management solutions, announced its support for the approval of security standards for the electronic prescribing (ePrescribing) of controlled substances and its commitment to assist the U.S. Drug Enforcement Administration (DEA) and the healthcare industry in implementation of the Interim Final Rule for ePrescribing controlled substances. Read more...